At the same time, through western blotting, the down-regulation of PDK4 was intriguingly noted to enhance the phosphorylated protein levels of ASK1 and JNK in MCF-7 cells (Fig. 4), implying that PDK4 silence might function as an activator of ASK1/JNK signaling in breast cancer cells. Here, MAP3K5 is linked to breast cancer.